Influence of Oligohydramnios on Preterm Premature Rupture of the Membranes at 30 to 36 Weeks' Gestation

Journal of Obstetrics and Gynaecology Canada

Volumn 32, Issue 11, 2010, Pages 1030-1034

  Coolen, Jillian ^a,b   Kabayashi, Koichi ^b,c   Wong, Karen ^b   Mayes, Damon C ^d   Bott, Nancy ^b   Demianczuk, Nestor ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Social Insurance Chuo General Hospital   (Japan)

^d ALBERTA HEALTH SERVICES   (Canada)

Author keywords

Amniotic fluid index; Maternal morbidity; Neonatal morbidity; Oligohydramnios; Preterm premature rupture of the membranes

Indexed keywords

AMOXICILLIN; CORTICOSTEROID; ERYTHROMYCIN;

AMNION FLUID ANALYSIS; ANTIBIOTIC THERAPY; ARTICLE; CHORIOAMNIONITIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOMETRITIS; FEMALE; GESTATIONAL AGE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFECTION RISK; LENGTH OF STAY; MAJOR CLINICAL STUDY; NEWBORN INTENSIVE CARE; NEWBORN MORBIDITY; NEWBORN MORTALITY; OLIGOHYDRAMNIOS; OUTCOME ASSESSMENT; PARITY; PREGNANCY OUTCOME; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURITY; PROGNOSIS; RETROSPECTIVE STUDY; BIRTH WEIGHT; ECHOGRAPHY; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; SEPSIS; STATISTICS;

BIRTH WEIGHT; COHORT STUDIES; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INTENSIVE CARE, NEONATAL; LENGTH OF STAY; OLIGOHYDRAMNIOS; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SEPSIS;

EID: 79952201971     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)34709-0     Document Type: Article

References (17)

1. Meis P.J., Ernest J.M., Moore M.L. Causes of low birth weight births in public and private patients. Am J Obstet Gynecol 1987, 156:1165-1168.
2. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics Premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. ACOG Practice Bulletin, No. 80. Obstet Gynecol 2007, 109:1007-1019. ACOG Practice Bulletin, No. 80. Obstet Gynecol.
3. Mercer B.M., Rabello Y.A., Thurnau G.R., Miodovnik M., Goldenberg R.L., Das A.F., et al. The NICHD-MFMU antibiotic treatment of preterm PROM study: impact of initial amniotic fluid volume on pregnancy outcome. NICHD-MFMU Network. Am J Obstet Gynecol 2006, 194:438-445.
4. Park J.S., Yoon B.H., Romero R., Moon J.B., Oh S.H., Kim J.C., et al. The relationship between oligohydramnios and the onset of preterm labour in preterm premature rupture of membranes. Am J Obstet Gynecol 2001, 184:459-462.
5. Ghidini A., Salafia C.M., Minior V.K. Repeated courses of steroids in preterm membrane rupture do not increase the risk of histologic chorioamnionitis. Am J Perinatol 1997, 14(6):309-313.
6. Gonik B., Bottoms S.F., Cotton D.B. Amniotic fluid volume as a risk factor in preterm premature rupture of the membranes. Obstet Gynecol 1985, 65:456-459.
7. Am Vintzileos, Campbell W.A., Nochimson D.J., Weinbaum P.J. Degree of oligohydramnios and pregnancy outcome in patients with premature rupture of the membranes. Obstet Gynecol 1985, 66:162-167.
8. Lao T.T., Cheung V.Y. Expectant management of preterm premature rupture of membranes-the significance of oligohydramnios at presentation. Eur J Obstet Gynecol Reprod Biol 1993, 48:87-91.
9. Carroll S.G., Papaioannou S., Nicolaides K.H. Assessment of fetal activity and amniotic fluid volume in the prediction of intrauterine infection in preterm premature amniorrhexis. Am J Obstet Gynecol 1995, 172:1427-1435.
10. Espinoza J., Chaiworapongsa T., Romero R., Edwin S., Rathnasabapathy C., Gomez R., et al. Antimicrobial peptides in amniotic fluid: defensins, calprotectin and bacterial/permeability-increasing protein in patients with microbial invasion of the amniotic cavity, intra-amniotic inflammation, preterm labour and premature rupture of membranes. J Matern Fetal Neonatal Med 2003, 1:2-21.
11. Mercer B.M., Crocker L.G., Boe N.M., Sibai B.M. Induction versus expectant management in premature rupture of the membranes with mature amniotic fluid at 32 to 36 weeks: a randomized trial. Am J Obstet Gynecol 1993, 169:775-782.
12. Hannah M.E., Ohlsson A., Farine D., Hewson S.A., Hodnett E.D., Myhr T.L., et al. Induction of labour compared with expectant management for prelabor rupture of the membranes at term. TERMPROM Study Group. N Engl J Med 1996, 334:1005-1010.
13. Mercer M.B., Miodovnik M., Thurnau G.R., Goldenberg R.L., Das A.F., Ramsey R.D., et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial, NICHD-MFMU Network. JAMA 1997, 278:989-995.
14. Kenyon S.L., Taylor D.J., Tarnow-Mordi W. Broad-spectrum antibiotics for preterm, premature rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet 2001, 357:979-988.
15. Kenyon S., Boulvain M., Neilson J. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev 2003, (Issue 2). Art No.: CD001058.
16. Harding J.E., Pang J., Knight D.B., Liggins G.C. Do antenatal corticosteroids help in the setting of preterm rupture of membranes?. Am J Obstet Gynecol 2001, 184:131-139.
17. Roberts D., Dalziel S. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006, (Issue 3). Art No.: CD004454.